Malignant melanoma, the most dangerous type of skin cancer, is estimated to affect roughly one in every 65 adults. Although it is typically preventable, the only treatment is surgical tumor excision. Unfortunately, it is often difficult to prevent the cancer from spreading due to melanoma's high malignancy rates.

Scientists at the University of Leeds recently found that a DNA defect in the apoptosis mediator gene CASP8 significantly increases the risk of melanoma [PMID: 21983787]. Additionally, researchers at the Georgetown University School of Medicine discovered that one fifth of melanomas have a defective copy of the STAG2 Gene, which plays a role in the division of genetic material between cells. [PMID: 2021852505]. These exciting new discoveries offer promise for potential future treatments, and open important new avenues for melanoma research.

Here at Novus Biologicals we offer a number of CASP8 and STAG2 Antibodies, a few of which can be found below: